|
SERF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47880000467282E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27260000004625E-06 |
| Normal-vs-Stage2 |
4.730000E-02 |
| Normal-vs-Stage3 |
9.412700E-04 |
| Normal-vs-Stage4 |
3.259800E-02 |
| Stage1-vs-Stage2 |
6.953000E-01 |
| Stage1-vs-Stage3 |
6.210200E-01 |
| Stage1-vs-Stage4 |
6.841600E-01 |
| Stage2-vs-Stage3 |
4.396000E-01 |
| Stage2-vs-Stage4 |
4.976000E-01 |
| Stage3-vs-Stage4 |
9.256000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.17289999724113E-08 |
| Normal-vs-AfricanAmerican |
5.379800E-04 |
| Normal-vs-Asian |
1.112090E-02 |
| Caucasian-vs-AfricanAmerican |
8.784200E-01 |
| Caucasian-vs-Asian |
1.152200E-01 |
| AfricanAmerican-vs-Asian |
1.697830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03410000007464E-07 |
| Normal-vs-Female |
2.982500E-04 |
| Male-vs-Female |
4.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.361860E-04 |
| Normal-vs-Extreme_Weight |
1.73290000016202E-07 |
| Normal-vs-Obese |
4.462900E-03 |
| Normal-vs-Extreme_Obese |
1.034430E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.252800E-01 |
| Normal_Weight-vs-Obese |
1.160360E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.831400E-01 |
| Extreme_Weight-vs-Obese |
1.942650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.144800E-01 |
| Obese-vs-Extreme_Obese |
6.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.189900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.72729999999533E-05 |
| Normal-vs-Age(61-80Yrs) |
6.99890000399606E-08 |
| Normal-vs-Age(81-100Yrs) |
2.247900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.440800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.616400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.426400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.948400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.997000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.831000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.92909999775193E-08 |
| Normal-VS-Type2 PRCC |
5.592600E-04 |
| Normal-VS-KIRP CIMP |
8.796400E-02 |
| Normal-VS-Unclassified PRCC |
9.430200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.812000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.765400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.267400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.059600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.507600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.307000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67929999994598E-06 |
| Normal-vs-N1 |
6.220000E-02 |
| Normal-vs-N2 |
2.408800E-01 |
| N0-vs-N1 |
1.585810E-01 |
| N0-vs-N2 |
8.976600E-01 |
| N1-vs-N2 |
4.601600E-01 |
|
|
